Abstract
Loss of an eye to tumor, trauma, or end stage ocular disease is a devastating condition. There is a loss of binocular vision with a reduced field of vision and loss of depth perception. Job limitations are often a result of lost binocularity, and affected individuals may experience a sense of facial disfigurement and poor self-esteem. The psychological trauma to the patient from loss of the eye may be worse than the physical disability in some instances. Few operations in ophthalmic surgery requires as much compassion on the part of the ophthalmologist as that needed to counsel a patient preparing to undergo removal of an eye. The anophthalmic surgeon must outline expected postoperative care and appearance, review potential problems, and provide emotional assistance in returning the patient to a productive life. Since eye contact is such an essential part of human interaction, it is extremely important for the artificial eye patient to maintain a natural, normal appearing prosthetic eye.
The authors of this study do not have a commercial or proprietary interest in any of the products reviewed in this manuscript.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gougelmann HP. The evolution of the ocular motility implant. Int Ophthalmol Clin. 1976;10:689–711.
Luce CM. A short history of enucleation. Int Ophthalmol Clin. 1970;10:681–7.
Cutler NL. A basket type of implant for use after enucleation. Arch Ophthalmol. 1946;35:71–4.
Grinsdale H. Notes on early case of Mules’ operation. Br J Ophthalmol. 1919;8:452–6.
Bartisch G. Ophthalmodouleica oder Augendienst, Dresden, 1583. In: Wood CA, editor. A system of ophthalmic operations. Chicago: Cleveland Press; 1911. p. 511.
Kelley JJ. History of ocular prosthesis. Int Ophthalmol Clin. 1970;10:713.
Hirshberg J. The history of ophthalmology, volume 5. The renaissance of ophthalmology in the 18th century, (part 3). The first half of the 19th century (part 1). Bonn: JP Wayenborgh/Verlag; 1985. p. 366.
Rudeman Jr AD. Modified Burch type evisceration with scleral implant. Am J Ophthalmol. 1960;49:41–4.
Witteman GJ, Scott R. Enucleation and evisceration. In: Peyman GA, Sanders DR, Goldberg MF, editors. Principles and practice of ophthalmology. Philadelphia: WB Saunders; 1980.
King Jr JH, Wadsworth JAC. An atlas of ophthalmic surgery. 3rd ed. Philadelphia: JB Lippincott; 1981.
Mules PH. Evisceration of the globe, with artificial vitreous. Trans Ophthalmol Soc UK. 1885;5:200–6.
Allen TD. Guist’s bone spheres. Am J Ophthalmol. 1930;13:226–30.
McCoy LL. Guist bone spheres. Am J Ophthalmol. 1932;15:960–3.
Spaeth EB. The principles and practices of ophthalmic surgery. In: Malvern PA, editor. Lea and Feabiger; 1941. pp. 127–142.
Ruedemann AD. Plastic eye implants. Am J Ophthalmol. 1946;29:947–51.
Cutler NL. A universal type integrated implant. Am J Ophthalmol. 1949;32:253–8.
Allen JH, Allen L. A buried muscle cone implant: I. Development of a tunnelled hemispherical type. Arch Ophthalmol. 1950;43:879–90.
Allen LH, Ferguson III EC, Braley AE. A quasi integrated buried muscle cone implant with good motility and advantages for prosthetic filling. Trans Am Acad Ophthalmol Otolaryngol. 1960;64:272–8.
Spivey BE, Allen LH, Burns CA. The Iowa enucleation implant: a ten year evaluation of techniques and results. Am J Ophthalmol. 1969;67:171–81.
Jordan DR, Anderson RL, Nerad JA, Allen L. A preliminary report on the universal implant. Arch Ophthalmol. 1987;105:1726–31.
Jordan DR, Anderson RL. The universal implant as an evisceration implant. Ophthalmic Plast Reconstr Surg. 1997;13:1–7.
Soll DB. Expandable orbital implants. In: Turtz A, editor. Proceedings of the centennial symposium, Manhattan Eye, Ear, and Throat Hospital, Vol I: Ophthalmology. St Louis: Mosby; 1969. pp. 197–202.
Hornblass A, Biesman BS, Eviatar JA. Current techniques of enucleation: a survey of 5,439 intraorbital implants and a review of the literature. Ophthalmic Plast Reconstr Surg. 1995;11:77–88.
Perry AC. Advances in enucleation. Ophthalmic Plast Reconstr Surg. 1991;4:173–82.
Dutton JJ. Coralline hydroxyapatite as an ocular implant. Ophthalmology. 1991;98:370–7.
Nunery WR, Heinz GW, Bonnin JM, et al. Exposure rate of hydroxyapatite spheres in the anophthalmic socket: histopathologic correlation and comparison with silicone sphere implants. Ophthalmic Plast Reconstr Surg. 1993;9:96–104.
Goldberg RA, Holds JB, Ebrahimpour J. Exposed hydroxyapatite orbital implants: report of six cases. Ophthalmology. 1992;99:831–6.
Kim YD, Goldberg RA, Shorr N, et al. Management of exposed hydroxyapatite orbital implants. Ophthalmology. 1994;101:1709–15.
Remulla HD, Rubin PAD, Shore JW, et al. Complications of porous spherical orbital implants. Ophthalmology. 1995;102:586–93.
Oestreicher JH, Liu E, Berkowitz M. Complications of hydroxyapatite orbital implants: a review of 100 consecutive cases and a comparison of Dexon mesh (polyglycolic acid) with scleral wrapping. Ophthalmology. 1997;104:324–9.
Jordan DR, Brownstein S, Jolly SS. Abscessed hydroxyapatite orbital implants: a report of two cases. Ophthalmology. 1996;103:1784–7.
Yoon JS, Lew H, Kim SJ, et al. Exposure rate of hydroxyapatite orbital implants. Ophthalmology. 2008;115:566–72.
Shoamanesh A, Pang N, Oestreicher JH. Complications of orbital implants: a review of 542 patients who have undergone orbital implantation and 275 subsequent peg placements. Orbit. 2007;25:173–82.
Custer PL, Trinkaus KM. Porous implant exposure: incidence, management, and morbidity. Ophthalmic Plast Reconstr Surg. 2007;23:1–7.
Jordan DR, Klapper SR, Gilberg SM. The use of vicryl mesh in 200 porous orbital implants. Ophthalmic Plast Reconstr Surg. 2003;19:53–61.
Wang JK, Liao SL, Lai PC, et al. Prevention of exposure of porous orbital implants following enucleation. Am J Ophthalmol. 2007;143:61–7.
Mawn L, Jordan DR, Gilberg S. Scanning electron microscopic examination of porous orbital implants. Can J Ophthalmol. 1998;33:203–9.
Jordan DR, Munro SM, Brownstein S, et al. A synthetic hydroxyapatite implant: the so-called counterfeit implant. Ophthalmic Plast Reconstr Surg. 1998;14(4):244–9.
Jordan DR, Bawazeer A. Experience with 120 synthetic hydroxyapatite implants (FCI3). Ophthalmic Plast Reconstr Surg. 2001;17:184–90.
Jordan DR, Pelletier C, Gilberg S, et al. A new variety of hydroxyapatite: the Chinese implant. Ophthalmic Plast Reconstr Surg. 1999;15:420–4.
Jordan DR, Hwang I, McEachren TM, et al. Brazilian hydroxyapatite implant. Ophthalmic Plast Reconstr Surg. 2000;16:363–9.
Jordan DR, Brownstein S, Gilberg S, et al. Investigation of a bioresorbable orbital implant. Ophthalmic Plast Reconstr Surg. 2002;18:342–8.
Klett A, Guthoff R. Muscle pedunculated scleral flaps. A microsurgical modification to improve prosthesis motility. Ophthalmologe. 2003;100:449–52.
Blaydon SM, Shepler TR, Neuhaus RW, et al. The porous polyethylene (Medpor) spherical orbital implant: a retrospective study of 136 cases. Ophthalmic Plast Reconstr Surg. 2003;19:364–71.
Karesh JW, Dresner SC. High-density porous polyethylene (Medpor) as a successful anophthalmic socket implant. Ophthalmology. 1994;101:1688–95.
Rubin PA, Popham J, Rumelt S, et al. Enhancement of the cosmetic and functional outcome of enucleation with the conical orbital implant. Ophthalmology. 1998;105:919–25.
Anderson RL, Yen MT, Lucci LM, et al. The quasi-integrated porous polyethylene orbital implant. Ophthalmic Plast Reconstr Surg. 2002;18:50–5.
Naik MN, Murthy RK, Honavar SG. Comparison of vascularization of Medpor and Medpor-Plus orbital implants: a prospective, randomized study. Ophthalmic Plast Reconstr Surg. 2007;23:463–7.
Mawn LA, Jordan DR, Gilberg S. Proliferation of human fibroblasts in vitro after exposure to orbital implants. Can J Ophthalmol. 2001;36:245–51.
Marx DP, Vagefi MR, Bearden WH, et al. The quasi-integrated porous polyethylene implant in pediatric patients enucleated for retinoblastoma. Orbit. 2008;27:403–6.
Chuo JY, Dolman PJ, Ng TL, et al. Clinical and histopathologic review of 18 explanted porous polyethylene orbital implants. Ophthalmology. 2009;116:349–54.
Alwitry A, West S, King J, et al. Long-term follow-up of porous polyethylene spherical implants after enucleation and evisceration. Ophthalmic Plast Reconstr Surg. 2007;23:11–5.
Christel P. Biocompatibility of alumina. Clin Orthop. 1992;282:10–8.
Cook S, Dalton J. Biocompatibility and biofunctionality of implanted materials. Alpha Omegan. 1992;85:41–7.
Jordan DR, Mawn L, Brownstein S, et al. The bioceramic orbital implant: a new generation of porous implants. Ophthalmic Plast Reconstr Surg. 2000;16:347–55.
Jordan DR, Gilberg S, Mawn LA. The bioceramic orbital implant: experience with 107 implants. Ophthalmic Plast Reconstr Surg. 2003;19:128–35.
Jordan DR, Gilberg S, Bawazeer A. Coralline hydroxyapatite orbital implant (bio-eye): experience with 158 patients. Ophthalmic Plast Reconstr Surg. 2004;20:69–74.
Wang JK, Lai PC, Liao SL. Late exposure of the bioceramic orbital implant. Am J Ophthalmol. 2009;147:162–70.
Su GW, Yen MT. Current trends in managing the anophthalmic socket after primary enucleation and evisceration. Ophthalmic Plast Reconstr Surg. 2004;20:274–80.
Jordan DR, Anderson RL, Nerad JA, et al. A preliminary report on the universal implant. Arch Ophthalmol. 1987;105:1726–31.
Guillinta P, Vasani SN, Granet DB, et al. Prosthetic motility in pegged versus unpegged integrated porous orbital implants. Ophthalmic Plast Reconstr Surg. 2003;19:119–22.
Custer PL, Kennedy RH, Woog JJ, et al. Orbital implants in enucleation surgery: a report by the American Academy of Ophthalmology. Ophthalmology. 2003;110:2054–61.
Custer PL, Trinkaus KM, Fornoff J. Comparative motility of hydroxyapatite and alloplastic enucleation implants. Ophthalmology. 1999;106:513–6.
Colen TP, Paridaens DA, Lemij HG, et al. Comparison of artificial eye amplitudes with acrylic and hydroxyapatite spherical enucleation implants. Ophthalmology. 2000;07:1889–94.
Perry JD, Tam RC. Safety of unwrapped spherical orbital implants. Ophthalmic Plast Reconstr Surg. 2004;20:281–4.
Trichopoulos N, Augsburger JJ. Enucleation with unwrapped porous and nonporous orbital implants: a 15-year experience. Ophthalmic Plast Reconstr Surg. 2005;1:331–6.
Gundlach KKH, Gutoff RF, Hingst VHM, et al. Expansion of the socket and orbit for congenital clinical anophthalmia. Plast Reconstr Surg. 2005;116:1214–22.
Dunaway DJ, David DJ. Intraorbital tissue expansion in the management of congenital anophthalmos. Br J Plast Surg. 1996;49:529–33.
Sinclair D, Dangerfiled P. Nervous system. In: Sinclair D, Dangerfield P, editors. Human growth after birth. Oxford: Oxford University Press; 1998. p. 87.
Bentley RP, Sgouros S, Natarajan K, et al. Normal changes in orbital volume during childhood. J Neurosurg. 2002;96:742–6.
Yago K, Furuta M. Orbital growth after unilateral enucleation in infancy without an orbital implant. Jpn J Ophthalmol. 2001;45:648–52.
Furuta M. Measurement of orbital volume by computed tomography: especially on the growth of the orbit. Jpn J Ophthalmol. 2000;104:724–8.
Farkas LG, Posnick JC, Hrecko TM. Growth patterns in the orbital region: a morphometric study. Cleft Palate Craniofac J. 1992;29:315–8.
Apt L, Isenberg S. Changes in orbital dimensions following enucleation. Arch Ophthalmol. 1973;90:393–5.
Kennedy RE. The effect of early enucleation on the orbit in animals and humans. Trans Am Ophthalmol Soc. 1964;62:459–510.
Pfieffer RL. The effect of enucleation on the orbit. Trans Am Acad Ophthalmol. 1945;49:236–9.
Taylor W. Effect of enucleation of one eye in childhood upon subsequent development of the face. Trans Ophthalmol Soc UK. 1939;59:368–73.
Hintschich C, Zonneveld F, Baldeschi L, et al. Bony orbital development after early enucleation in humans. Br J Ophthalmol. 2001;85:205–8.
Howard GM, Kinder RS, MacMillan Jr AS. Orbital growth after uniltateral enucleation in childhood. Arch Ophthalmol. 1965;73:80–3.
Imhof SM, Mourits MP, Hofman P, et al. Quantification of orbital and mid-facial growth retardation after megavoltage external beam irradiation in children with retinoblastoma. Ophthalmology. 1996;103:263–8.
Cepela MA, Nunery WR, Martin RT. Stimulation of orbital growth by the use of expandable implants in the anophthalmic cat orbit. Ophthalmic Plast Reconstr Surg. 1992;8:157–67.
Kaste SC, Chen G, Fontanesi J, et al. Orbital development in long-term survivors of retinoblastoma. J Clin Oncol. 1997;15:1183–9.
Fountain TR, Goldberger S, Murphree AL. Orbital development after enucleation in early childhood. Ophthalmic Plast Reconstr Surg. 1999;15:32–6.
Heher KL, Katowitz JA, Low JE. Unilateral dermis-fat graft implantation in the pediatric orbit. Ophthalmic Plast Reconstr Surg. 1998;14:81–8.
Mitchell KT, Hollsten DA, White WL, et al. The autogenous dermis-fat orbital implant in children. J AAPOS. 2001;5:367–9.
Nunery WR, Hetzler KJ. Dermal-fat graft as a primary enucleation technique. Ophthalmology. 1985;92:1256–61.
Migliori ME, Putterman AM. The domed dermis-fat graft orbital implant. Ophthalmic Plast Reconstr Surg. 1991;7:23–30.
DePotter P, Shields CL, Shields JA, et al. Use of the hydroxyapatite ocular implant in the pediatric population. Arch Ophthalmol. 1994;112:208–12.
Iordanidou V, De PP. Porous polyethylene orbital implant in the pediatric population. Am J Ophthalmol. 2004;138:425–9.
Wang JK, Liao SL, Lin LL, et al. Porous orbital implants, wraps, and PEG placement in the pediatric population after enucleation. Am J Ophthalmol. 2007;144:109–16.
DePotter P, Shields CL, Shields JA, et al. Role of magnetic resonance imaging in the evaluation of the hydroxyapatite orbital implant. Ophthalmology. 1992;99:824–30.
Arora V, Weeks K, Halperin EC, et al. Influence of coralline hydroxyapatite used as an ocular implant on the dose distribution of external beam photon radiation therapy. Ophthalmology. 1992;99:380–2.
Kaltreider SA. The ideal ocular prosthesis: analysis of prosthetic volume. Ophthalmic Plast Reconstr Surg. 2000;16:388–92.
Kaltreider SA, Lucarelli MJ. A simple algorithm for selection of implant size for enucleation and evisceration. Ophthalmic Plast Reconstr Surg. 2002;18:336–41.
Custer PL, Trinkaus KM. Volumetric determination of enucleation implant size. Am J Ophthalmol. 1999;128:489–49492.
Thaller VT. Enucleation volume measurement. Ophthalmic Plast Reconstr Surg. 1997;13:18–20.
Kaltreider SA, Jacobs JL, Hughes MO. Predicting the ideal implant size before enucleation. Ophthalmic Plast Reconstr Surg. 1999;15:37–43.
Perry JD. Hydroxyapatite implants (letter). Ophthalmology. 2003;110:1281–3.
Long JA, Tann III TM, Bearden III WH, et al. Enucleation: is wrapping the implant necessary for optimal motility? Ophthalmic Plast Reconstr Surg. 2003;19:194–7.
Suter AJ, Molteno AC, Bevin TH, et al. Long term follow up of bone derived hydroxyapatite orbital implants. Br J Ophthalmol. 2002;86:1287–92.
Li T, Shen J, Duffy MT. Exposure rates of wrapped and unwrapped orbital implants following enucleation. Ophthalmic Plast Reconstr Surg. 2001;17:431–5.
Jordan DR, Klapper SR. Wrapping hydroxyapatite implants. Ophthalmic Surg Lasers. 1999;30:403–7.
Jordan DR. Localization of extraocular muscles during secondary orbital implantation surgery: the tunnel technique: experience in 100 patients. Ophthalmology. 2004;111:1048–54.
Nunery WR. Risk of prion transmission with the use of xenografts and allografts in surgery. Ophthalmic Plast Reconstr Surg. 2003;17:389–94.
Seiff SR, Chang Jr JS, Hurt MH, et al. Polymerase chain reaction identification of human immunodeficiency virus-1 in preserved human sclera. Am J Ophthalmol. 1994;118:528–9.
Lang CJ, Heckmann JG, Neundorfer B. Creutzfeldt-Jakob disease via dural and corneal transplants. J Neurol Sci. 1998;160:128–39.
Brooke FJ, Boyd A, Klug GM, et al. Lyodura use and the risk of iatrogenic Creutzfeldt-Jakob disease in Australia. Med J Aust. 2004;180:177–81.
Hogan RN, Brown P, Heck E, et al. Risk of prion disease transmission from ocular donor tissue transplantation. Cornea. 1999;18:2–11.
Heckmann JG, Lang CJ, Petruch F, et al. Transmission of Creutzfeldt-Jakob disease via a corneal transplant. J Neurol Neurosurg Psychiatry. 1997;63:388–90.
Simonds RJ, Holmberg SD, Hurwitz RL, et al. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N Engl J Med. 1992;326:726–32.
Arat YO, Shetlar DJ, Boniuk M. Bovine pericardium versus homologous sclera as a wrapping for hydroxyapatite orbital implants. Ophthalmic Plast Reconstr Surg. 2003;19:189–93.
Gayre GS, DeBacker CM, Lipham W, et al. Bovine pericardium as a wrapping for orbital implants. Ophthalmic Plast Reconstr Surg. 2001;17:381–7.
Pelletier CR, Jordan DR, Gilberg SM. Use of temporalis fascia for exposed hydroxyapatite orbital implants. Ophthalmic Plast Reconstr Surg. 1998;14:198–203.
Naugle Jr TC, Fry CL, Sabatier RE, et al. High leg incision fascia lata harvesting. Ophthalmology. 1997;104:1480–8.
Kao SCS, Chen S. The use of rectus abdominis sheath for wrapping of the hydroxyapatite orbital implants. Ophthalmic Surg Lasers. 1999;30:69–71.
Naugle Jr TC, Lee AM, Haik BG, et al. Wrapping hydroxyapatite orbital implants with posterior auricular muscle complex grafts. Am J Ophthalmol. 1999;128:495–501.
Karesh JW. Polytetrafluoroethylene as a graft material in ophthalmic plastic and reconstructive surgery: an experimental and clinical study. Ophthalmic Plast Reconstr Surg. 1987;3:179–85.
Choo PH, Carter SR, Crawford JB, et al. Exposure of expanded polytetrafluoroethylene-wrapped hydroxyapatite orbital implant: a report of two patients. Ophthalmic Plast Reconstr Surg. 1999;15:77–8.
Kao L. Polytetrafluoroethylene as a wrapping material for a hydroxyapatite orbital implant. Ophthalmic Plast Reconstr Surg. 2000;16:286–8.
Heimann H, Bechrakis NE, Zepeda LC, et al. Exposure of orbital implants wrapped with polyester-urethane after enucleation for advanced retinoblastoma. Ophthalmic Plast Reconstr Surg. 2005;21:123–8.
Klapper SR, Jordan DR, Punja K, et al. Hydroxyapatite implant wrapping materials: analysis of fibrovascular ingrowth in an animal model. Ophthalmic Plast Reconstr Surg. 2000;16:278–85.
Jordan DR, Allen LH, Ells A, et al. The use of vicryl mesh (polyglactin 910) for implantation of hydroxyapatite orbital implants. Ophthalmic Plast Reconstr Surg. 1995;11:95–9.
Jordan DR, Ells A, Brownstein S, et al. Vicryl-mesh wrap for the implantation of hydroxyapatite orbital implants: an animal model. Can J Ophthalmol. 1995;30:241–6.
Gayre GS, Lipham W, Dutton JJ. A comparison of rates of fibrovascular ingrowth in wrapped versus unwrapped hydroxyapatite spheres in a rabbit model. Ophthalmic Plast Reconstr Surg. 2002;18:275–80.
Custer PL. Enucleation: past, present, and future. Ophthalmic Plast Reconstr Surg. 2000;16:316–21.
Custer PL. Reply to Dr. D.R. Jordan’s letter on polyglactin mesh wrapping of hydroxyapatite implants. Ophthalmic Plast Reconstr Surg. 2001;17:222–3.
Inkster CF, Ng SG, Leatherbarrow B. Primary banked sclera patch graft in the prevention of exposure of hydroxyapatite orbital implants. Ophthalmology. 2002;109:389–92.
Jordan DR, Chan S, Mawn L, et al. Complications associated with pegging hydroxyapatite orbital implants. Ophthalmology. 1999;106:505–12.
Edelstein C, Shields CL, DePotter P, et al. Complications of motility peg placement for the hydroxyapatite orbital implant. Ophthalmology. 1997;104:1616–21.
Lin CJ, Liao SL, Jou JR, et al. Complications of motility peg placement for porous hydroxyapatite orbital implants. Br J Ophthalmol. 2002;86:394–6.
Jordan DR. Spontaneous loosening of hydroxyapatite peg sleeves. Ophthalmology. 2001;108:2041–4.
Cheng MS, Liao SL, Lin LL. Late porous polyethylene implant exposure after motility coupling post placement. Am J Ophthalmol. 2004;138:420–4.
Lee SY, Jang JW, Lew H, et al. Complications in motility PEG placement for hydroxyapatite orbital implant in anophthalmic socket. Jpn J Ophthalmol. 2002;46:103–7.
Fahim DK, Frueh BR, Musch DC, et al. Complications of pegged and non-pegged hydroxyapatite orbital implants. Ophthalmic Plast Reconstr Surg. 2007;23:206–10.
Yazici B, Akova B, Sanli O. Complications of primary placement of motility post in porous polyethylene implants during enucleation. Am J Ophthalmol. 2007;143:828–34.
Jordan DR, Klapper SR. A new titanium peg system for hydroxyapatite orbital implants. Ophthalmic Plast Reconstr Surg. 2000;16:380–7.
Ainbinder DJ, Haik BG, Tellado M. Hydroxyapatite orbital implant abscess: histopathologic correlation of an infected implant following evisceration. Ophthalmic Plast Reconstr Surg. 1994;10:267–70.
Klapper SR, Jordan DR, Ells A, et al. Hydroxyapatite orbital implant vascularization assessed by magnetic resonance imaging. Ophthalmic Plast Reconstr Surg. 2003;19:46–52.
Choi JC, Iwamoto MA, Bstandig S, et al. Medpor motility coupling post: a rabbit model. Ophthalmic Plast Reconstr Surg. 1999;15:190–201.
Rubin PAD, Fay AM, Remulla HD. Primary placement of motility coupling post in porous polyethylene orbital implants. Arch Ophthalmol. 1999;118:826–32.
Hsu WC, Green JP, Spilker MH, et al. Primary placement of a titanium motility post in a porous polyethylene orbital implant. Ophthalmic Plast Reconstr Surg. 2003;16:370–9.
Liao SL, Chen MS, Lin LL. Primary placement of a titanium sleeve in hydroxyapatite orbital implants. Eye. 2005;19:400–5.
Liao SL, Shih MJ, Lin LL. Primary placement of a hydroxyapatite-coated sleeve in bioceramic orbital implants. Am J Ophthalmol. 2005;139:235–41.
Jordan DR, Brownstein S, Faraji H. Clinicopathologic analysis of 15 explanted hydroxyapatite implants. Ophthalmic Plast Reconstr Surg. 2004;20:285–90.
Jordan DR, Klapper SR, Mawn L, et al. Abscess formation within a synthetic hydroxyapatite orbital implant. Can J Ophthalmol. 1998;33:329–33.
Klapper SR, Jordan DR, Brownstein S, et al. Incomplete fibrovascularization of a hydroxyapatite orbital implant 3 months after implantation. Arch Ophthalmol. 1999;106:1640–1.
Miller DM, Murray T, Suarez F, et al. Motility assessment and clinical outcomes of a magnetically integrated microporous implant. Ophthalmic Surg Lasers Imaging. 2007;38:339–41.
Nakara T, Ben Simon GY, Douglas RS. Comparing outcomes of enucleation and evisceration. Ophthalmology. 2006;113:2270–5.
Timothy NH, Freilich DE, Linberg JV. Evisceration versus enucleation from the ocularists’s perspective. Ophthalmic Plast Reconstr Surg. 2003;19:417–20.
Georgescu D, Reza Vagefi M, Lin Yang CC, McCann J, Anderson RL. Evisceration with equatorial sclerotomy for phthisis bulbi ann microphthalmos. Ophthalmic Plast Reconstr Surg. 2010;26:165–7.
Jordan DJ, Parisi J. The scleral filet technique. Can J Ophthalmol. 1996;31(7):357–61.
Soll DB. Evisceration with eversion of the scleral shell and muscle cone positioning of the implant. Am J Ophthalmol. 1987;104:265–9.
Kostick DA, Linberg JV. Evisceration with hydroxyapatite implant. Surgical technique and review of 31 case reports. Ophthalmology. 1995;102:1542–9.
Jordan DR, Anderson RL. The universal implant for evisceration surgery. Ophthalmic Plast Reconstr Surg. 1997;13:1–7.
Long JA, Tann III TM, Girgin CA. Evisceration: a new technique of trans scleral implant placement. Ophthalmic Plast Reconstr Surg. 2000;5(3):322–5.
Massry GG, Holds JB. Evisceration with scleral modification. Ophthalmol Plast Reconstr Surg. 2001;17:42–7.
Ozgur OR, Akcay L, Dogan OK. Evisceration via superior temporal sclerotomy. Am J Ophthalmol. 2005;139:78–86.
Hart RH, Barnes E, Dickinson AJ. Secondary orbital implants after evisceration: a new conjunctiva-sparing technique. Ophthalmol Plast Reconstr Surg. 2005;21:129–32.
Sales-Sanz M, Sanz-Lopez A. Four-petal evisceration: a new technique. Ophthalmol Plast Reconstr Surg. 2007;23:389–92.
Masidottir S, Sahlin S. Patient satisfaction and results after evisceration with a split-sclera technique. Orbit. 2007;26:389–92.
Maumanee AE. Retrobulbar alcohol injection: relief of ocular pain in eyes with and without vision. Am J Ophthamol. 1949;32:1502–8.
Al-Faran MF, Al-Omar O. Retrobulbar alcohol injection in blind painful eyes. Ann Ophthalmol. 1990;22:460–2.
Olurin O, Osuntokun O. Complications of retrobulbar alcohol injections. Ann Ophthalmol. 1978;10:474–6.
Chen TC, Ahn Yuen SJ, Sangaalang MA, Fernando RE, Luenberger EU. Retrobulbar chlorpromazine injections for management of blind and seeing eyes. J Glaucoma. 2002;11:209–13.
Estafanous MFG, Kaiser PK, Baerveldt G. Retrobulbar chlorpromazine in blind and seeing eyes. Retina. 2000;20:555–8.
McCulley TJ, Kersten RC. Periocular inflammation after retrobulbar chlorpromazine (Thorazine) injection. Ophthalmic Plast Reconstr Surg. 2006;4:283–5.
Cotliar JM, Shields CL, Meyer DR. Chronic orbital inflammation and fibrosis after retrobulbar alcohol and chlorpromazine injections in a patient with choroidal melanoma. Ophthalmic Plast Reconstr Surg. 2008;24:410–1.
Burroughs JR, Soparkar CN, Patrinely JR, Kersten RC, Kulwin DR, Lowe CL. Monitored anesthesia care for enucleations and eviscerations. Ophthalmology. 2003;110(2):311–3.
Archer KF, Hurwitz JJ. Dermis-fat grafts and evisceration. Ophthalmology. 1989;96:170–4.
Borodic GE, Townsend DJ, Beyer-Machule CK. Dermis fat graft in eviscerated sockets. Ophthalmic Plast Reconstr Surg. 1989;5:144–9.
Lisman RD, Smith BC. Dermis-fat grafting. In: Smith BC, editor. Ophthalmic plastic and reconstructive surgery. St Louis: CV Mosby; 1987. p. 1308–20.
Saunders CK, Garber PF, Della Rocca RC. Socket reconstruction. In: Levine MR, editor. Manual of oculoplastic surgery. Philadelphia: Butterworth Heinemann; 2003. p. 314–6.
Spivey BE et al. The Iowa enucleation implant: a 10 year evolution of technique and results. Am J Opthalmol. 1969;67:171–7.
Anderson RL, Thiese SM, Nerad JA, et al. The universal orbital implant: indications and methods. Adv Ophthalmic Plast Reconstr Surg. 1990;8:88–99.
Levine MR, Pou CR, Lesh RH. The 1998 Wendell Hughes lecture. Evisceration: is sympathetic ophthalmia a concern in the new millenium? Ophthalmic Plast Reconstr Surg. 1999;15:4–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Jordan, D.R., Klapper, S.R. (2012). Enucleation, Evisceration, Secondary Orbital Implantation. In: Black, E., Nesi, F., Calvano, C., Gladstone, G., Levine, M. (eds) Smith and Nesi’s Ophthalmic Plastic and Reconstructive Surgery. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-0971-7_68
Download citation
DOI: https://doi.org/10.1007/978-1-4614-0971-7_68
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-0970-0
Online ISBN: 978-1-4614-0971-7
eBook Packages: MedicineMedicine (R0)